Syringes Market Growth by Region, Leading Companies, Drivers, 2026-2034
REPORT DETAILS
Syringes Market Summary
The global syringes market size was valued at USD 17.87 billion in 2025, growing at a CAGR of 8.55% from 2026 to 2034. Key drivers of syringe are the rising number of cases of diabetes globally and heightened government healthcare spending.
Market Statistics
Key Takeaways
- The syringes market in North America held the largest global market share of 40.18% in 2025.
- The U.S. syringes market is expanding at a CAGR of 7.30% during 2026–2034, owing to the widespread adoption of innovative drug-delivery systems and rising healthcare expenditure.
- The Asia Pacific market is expected to expand at a CAGR of 11.0% during 2026–2034, driven by the increasing prevalence of chronic diseases and growing pharmaceutical production.
- China is expected to grow at a CAGR of 10.50% during the forecast period, driven by large-scale vaccination programs, sophisticated medical device production, and favorable healthcare policies.
- The disposable syringes segment held the largest market share of 55.24% in 2025.
- The prefilled syringes segment is expected to expand at a CAGR of 11.20% during 2026–2034 due to rising demand for dosage accuracy, lower contamination risks, and greater patient convenience.
Note: Figures and projections outlined in this report are the result of Polaris Market Research’s proprietary analytical processes, grounded in the latest available datasets and market observations.
Industry Dynamics
- Rising diabetic cases worldwide is fueling the market growth due to increasing need for insulin delivery and frequent self-administration of injections.
- Growing government healthcare spending worldwide drive the demand for syringes due to large-scale immunization campaigns, public health initiatives, and investments in modern healthcare infrastructure.
- The expansion of biologics and specialty drugs, is expected to create lucrative opportunities during the forecast period.
- The growing scrutiny over medical waste and single-use plastic syringes is anticipated to restrain market growth.
What are Syringes?
The syringes market involves a broad array of medical devices utilized for injecting or withdrawing liquids in healthcare procedures. These devices are critical in hospitals, clinics, diagnostic laboratories, and home healthcare for delivering drugs, vaccination, blood sample withdrawal, and therapeutic purposes. Syringes are produced with different types, such as disposable, safety, and prefilled designs, to address various clinical needs while maintaining patient safety and infection prevention. The growing incidence of chronic conditions, increased vaccination programs, and growing demand for self-injecting devices are inducing large-scale adoption. Precision, safety, and efficiency are being emphasized in healthcare systems, aligning syringes as an essential part of contemporary medical delivery systems.
The rising rate of chronic diseases globally is driving the demand for syringes, as long-term management of chronic diseases involves repeated injections, immunotherapies, and biologic drugs. The increasing number of patients also need trustworthy and safe delivery systems to treat diseases like cancer, diabetes, and cardiovascular diseases. For the first time, the latest Eurostat data for 2026 shows that 35.3% of people aged 16 and above in the European Union reported having a long-standing illness or health problem. In Finland, the corresponding proportion was 56.0% and in Germany 36.2%. (Source: ec.europa.eu)This high disease burden emphasizes the role of syringes in effective treatment delivery in hospitals, clinics, specialty centres, and homecare.
Source: Polaris Market Research Analysis
Elderly population's growth stimulates the demand for syringes since elderly people undergo more surgical procedures, routine checkups, and preventive care treatments. With rising life expectancy, injectable therapies such as vaccines and routine health monitoring for quality aging are more intensively used. In light of the demographic transition, healthcare systems are striving to enhance medical services and care delivery, in turn increasing demand for syringes worldwide.
Drivers & Opportunities
Increasing Diabetic Cases Worldwide: The rising global incidence of diabetes is one of the key factors that is propelling the demand for syringes used for routine insulin therapy and other injectable treatments for effective management of the disease. The latest International Diabetes Federation (IDF) data for 2026 shows that 589 million adults aged 20–79 years are now living with diabetes worldwide, including an estimated 252 million undiagnosed cases. By 2050, the number of people with diabetes is expected to reach 853 million. (IDF Atlas) This increasing burden of disease is pushing healthcare systems to provide better access to safe and accurate insulin-delivery devices. As a result, healthcare providers are increasingly using advanced and disposable syringes in hospitals, clinics, and homecare settings, which is contributing to the growth of the syringe market.
Rising Government Healthcare Expenditure: Due to the rising government healthcare spending, the syringes market has been receiving a push, as expanding access to essential medical services under the auspices of government health schemes, vaccination programs, and hospital infrastructure. Even though this raises the bar for patient care in the prevalent healthcare systems, it also ensures that the supply of medical devices remains uninterrupted and allows the patient to benefit from injections that have gained newer technologies.
Source: Polaris Market Research Analysis
Segmental Insights
Usage Analysis
Based on usage, the segmentation includes sterilizable/reusable syringes, disposable syringes, and prefilled syringes. The disposable syringes segment dominated the market with 55.24% in 2025, due its universal use within hospitals and diagnostic clinics for normal procedures and immunization drives. The single-use nature greatly helps in minimizing the threat of cross-contamination and hospital-acquired infections, rendering it the choice in mass immunization programs. Moreover, government-sponsored vaccination programs in developed and emerging nations keep propelling the demand for disposable syringes.
The prefilled syringes segment is projected to expand at the fastest pace of 11.20% during the forecast period, owing to its increasing application in biologics injection, oncology, and chronic disease management like diabetes thereby driving adoption. Prefilled formats promote dosage accuracy, minimize preparation mistakes, and increase patient convenience, in self-administration contexts. For example, in June 2025. W.L. Gore launched its 0.5 mL silicone-free Gore ImProject syringe plunger, which is used for prefilled syringes in ophthalmic and other delicate use cases, commercially.
Difference Between Disposable vs Reusable vs Prefilled Syringes
| Feature | Disposable Syringes | Reusable Syringes | Prefilled Syringes |
| Safety | High; prevents reuse-related infections | Lower; needs proper sterilization | Very high; sterile and ready-to-use |
| Cost | Low cost, frequent replacement | Cost-effective for repeated use | Higher cost due to prefilled packaging |
| Convenience | Simple and widely available | Requires cleaning and handling | Highest convenience, saves preparation time |
| Contamination Risk | Low with single use | Higher due to repeated use | Minimal due to sealed packaging |
| Usage Trend | Largest market share due to infection control | Declining adoption | Growing demand in biologics and self-administration |
Material Analysis
Based on material, the market is categorized into glass syringes and plastic syringes. The plastic segment dominated the market 65.12% share in 2025 owing to cost efficiency lightweight structure and lower risk of breakage during handling and transportation its adaptability enables wide use in single use vaccination campaigns and therapeutic injections. This secures its position as a critical component in healthcare delivery.
Glass syringes are anticipated to grow steadily at a CAGR of 8.20% throughout the forecast period, fueled by compatibility with sensitive biologics, specialty injectables, and potent drugs. Chemical stability is provided by glass, as it avoids interactions with intricate formulation, making it the preferred material for the manufacture of biologics. The increased pipeline of injectable biologics and greater regulatory scrutiny on drug stability are crucial drivers for the growth of this segment.
Comparison Matrix: Plastic Syringes Vs Glass Syringes
| Feature | Plastic Syringes | Glass Syringes |
| Material Advantage | Lightweight, flexible, and cost-effective | High chemical resistance and premium material quality |
| Safety | Supports single-use design and reduces infection risk | Requires careful handling due to breakage risk |
| Cost | Lower production and disposal cost | Higher manufacturing cost |
| Drug Compatibility | Suitable for most standard medicines | Preferred for biologics and sensitive formulations |
| Market Trend | Dominant due to mass healthcare adoption | Growing in specialty drugs and prefilled applications |
Application Analysis
By application the market is segmented into vaccines and immunizations, anaphylaxis, diabetes, oncology and others. Where the vaccines and immunizations segment led with 30.14% share in 2025 driven by global vaccination programs influenza booster initiatives and procurement activities by regulatory bodies such as WHO and UNICEF that collectively sustained consistent syringe demand worldwide
The diabetes segment is expected to witness the fastest growth at a CAGR of 8.50% during 2026-2034, due to the increasing global prevalence of diabetes and growing dependence on injectable insulin with syringes serving as a primary mode for daily administration in regions. This insulin pens remain less accessible while rising awareness early detection and higher healthcare expenditure continue to strengthen adoption.
End User Analysis
Direct tenders commanded the highest market share of 35.04% in 2025, as governments and healthcare facilities buy syringes in bulk to sustain national immunization and therapeutic programs. Centralized procurement schemes provide cost savings and access to large quantities in the public health system.
The online pharmacies segment is anticipated to register the strongest growth at a CAGR of 12.50% over the forecast period due to the fast development of e-commerce in healthcare coupled with consumer demand for convenience and competitive pricing. Online platforms are increasingly making strides in emerging markets, where growing internet penetration and home delivery operations are revolutionizing healthcare access. The growth of chronic disease management kits and home-based care solutions is likely to further enhance this channel's market presence.
Source: Polaris Market Research Analysis
Regional Analysis
North America Syringes Market Overview
North America led the syringes market in 2025 with 40.18% share, due to robust healthcare infrastructure and growing demand for sophisticated drug delivery systems. Ongoing investment in vaccine programs, the management of chronic diseases, and injectable therapy is driving market growth in the region. Having well-established major medical device companies and a highly regulated healthcare environment further stimulates the production and dissemination of advanced technology syringes.
The U.S. Syringes Market Insights
The U.S. syringes market captured 79.97% share in 2025, propelled by the increasing cancer burden, as oncology treatments require repeated and accurate injectable delivery to administer chemotherapy, immunotherapy, and targeted biologics. Growing utilization of complex therapies including monoclonal antibodies and CAR-T cell therapies is also driving the demand for quality syringes to ensure safe and accurate drug preparation and administration. An estimated 2,114,850 new cases of cancer and 626,140 cancer deaths are projected to occur in the United States in 2026, the US having the highest incidence rates of colon, breast, and prostate cancer worldwide, and highest death rate for lung cancer. (Source: cancerstatisticscenter.cancer.org) Increasing syringe penetration in hospitals, oncology centers and specialty centers due to increasing cancer burden is expected to provide immense opportunity for healthcare providers and pharmaceutical companies to increase their revenue along with delivering accurate dosing, reducing medication errors and providing better patient care and treatment delivery.
Europe Syringes Market Assessments
The European market is expected to witness 25.32% share in 2025, due to the well-established pharmaceutical production base, growing incidence of chronic diseases, and focus on patient safety within clinical procedures. Preventive healthcare emphasis within the region, along with regulatory requirements for safety-engineered and single-use syringes, is fueling steady demand. Germany, France, and Italy are experiencing extensive consumption within hospitals, diagnostic facilities, and outpatient clinics, guaranteeing long-term market growth.
Asia Pacific Syringes Market Trends
Asia Pacific is expected to witness the quickest growth at a CAGR of 11.0% over the forecast period due to extensive use of safety syringes to reduce needle-stick injuries and increased vaccination programs in developing economies. Increased government funding in public health programs and increasing access to advanced medical facilities are fueling syringe adoption in urban as well as rural geographies. The growth of the region's pharmaceutical industry and vast patient population are also propelling demand for an extensive variety of syringes in therapeutic and prophylactic use.
India Syringes Market Overview
The India syringes market is expected to register a CAGR of 13.20% over the forecast period (2026–2034), owing to the developments in safety-engineered devices that enhance healthcare worker protection and infection control. Next-generation safety and auto-disable syringes decrease accidental needlestick injuries, prevent reuse, and help meet certain quality standards. In March 2026, the World Health Organization (WHO) prequalified Hindustan Syringes & Medical Devices' 2 mL KOJAK SELINGE auto-disable syringe. (Source: extranet.who.int) The India-made device has a plunger-locking or breaking mechanism that activates after injection and is compatible with the relevant ISO safety and quality standards. These regulatory successes and product innovations enhance the safety of patients and caregivers while facilitating the use of syringes in hospitals, clinics, immunization programs, and homecare settings, thereby contributing to overall market growth.
Source: Polaris Market Research Analysis
Key Players & Competitive Analysis
The syringes market is competitive, with prominent companies being Becton, Dickinson and Company (BD), Terumo Medical Corporation, Nipro Corporation, Gerresheimer AG, Schott AG, Cardinal Health, Inc., B. Braun SE, and Hindustan Syringes & Medical Devices Ltd. These players concentrate on offering innovative syringe solutions such as prefilled syringes, safety syringes, and specialty syringes to serve needs across drug delivery, vaccination, and the management of chronic diseases. The competitive dynamics are also influenced by introductions and alliances with pharmaceutical firms to provide big-scale production contracts. Growing investment in automated manufacturing, needle-stick injury prevention devices, and green materials is transforming the competitive dynamics.
A few major companies operating in the Syringes industry include Becton, Dickinson and Company, Terumo Medical Corporation, Nipro Corporation, Gerresheimer AG, Schott AG, Cardinal Health, Inc., B. Braun SE, Hindustan Syringes & Medical Devices Ltd., Wuxi Yushou Medical Appliances Co., Ltd., Syntegon Technology GmbH, Sharps Technology, Inc., and Vita Needle Company.
Key Players
- B. Braun SE
- Becton, Dickinson and Company
- Cardinal Health, Inc.
- Gerresheimer AG
- Hindustan Syringes & Medical Devices Ltd.
- Nipro Corporation
- Schott Pharma AG & Co. KGaA
- Sharps Technology, Inc.
- Syntegon Technology GmbH
- Terumo Medical Corporation
- Vita Needle Company
- Wuxi Yushou Medical Appliances Co., Ltd.
Syringes Industry Developments
- January 2026: Terumo Medical Corporation launched its SurTract Safety Syringe in the U.S. The syringe is powered by SafeR passive safety technology. This is developed by Roncadelle Operations S.r.l. (Source: terumo.com)
- BD expanded its partnership with Ypsomed to develop a 5.5 mL BD Neopak XtraFlow Glass Prefillable Syringe compatible with the YpsoMate 5.5 autoinjector platform. (Source: news.bd.com)
- April 2026, BD partnered with Suttons Creek to support pharmaceutical and biotechnology companies in developing and commercializing combination drug-delivery products. (Source: news.bd.com)
- April 2025: Syntegon introduced the MLD Advanced, a state-of-the-art filling machine designed for ready-to-use (RTU) nested syringes that combines proven technologies from vial and cartridge lines. It delivers high output and ensure precise filling and weight verification for each syringe. (Source: syntegon.com)
- April 2025: Gerresheimer launched syringe systems made of glass and cyclic olefin polymer that are completely free of silicone oil and PFAS, offering a safer solution for sensitive biologics and applications including ophthalmology. (Source: gerresheimer.com)
Syringes Market Segmentation
By Usage Outlook (Revenue, USD Billion, 2021–2034)
- Sterilizable/Reusable Syringes
- Hypodermic Syringes
- Oral Syringes
- Disposable Syringes
- Conventional Syringes
- Safety Syringes
- Retractable Safety Syringes
- Non-Retractable Safety Syringes
- Prefilled Syringes
By Material Outlook (Revenue, USD Billion, 2021–2034)
- Glass Syringes
- Plastic Syringes
By Application Outlook (Revenue, USD Billion, 2021–2034)
- Vaccines and Immunizations
- Anaphylaxis
- Diabetes
- Oncology
- Others
By End User Outlook (Revenue, USD Billion, 2021–2034)
- Direct Tenders
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Regional Outlook (Revenue, USD Billion, 2021–2034)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Syringes Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 17.87 Billion |
| Market Size in 2026 | USD 19.37 Billion |
| Revenue Forecast by 2034 | USD 37.32 Billion |
| CAGR | 8.55% from 2026 to 2034 |
| Base Year | 2025 |
| Historical Data | 2021–2024 |
| Forecast Period | 2026–2034 |
| Quantitative Units | Revenue in USD Billion and CAGR from 2026 to 2034 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Industry Trends |
| Segments Covered |
|
| Regional Scope |
|
| Competitive Landscape |
|
| Report Format |
|
| Customization | Report customization as per your requirements with respect to countries, regions, and segmentation. |
Source: Polaris Market Research Analysis
Syringes Market FAQ's
The global market size was valued at USD 17.87 billion in 2025 and is projected to grow to USD 37.32 billion by 2034.
The global market is projected to register a CAGR of 8.55% during the forecast period.
The syringes market in North America held the largest global market share of 40.18% in 2025.
A few of the key players in the market are B. Braun SE, Becton, Dickinson and Company, Cardinal Health, Inc., Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd., Nipro Corporation, Schott Pharma AG & Co. KGaA, Sharps Technology, Inc., Syntegon Technology GmbH, Terumo Corporation
Growth is led by the expanding vaccination programs, injectable biologics, chronic disease burden, self-administration of medicines, demand for prefilled syringes, and adoption of?safety-engineered injection devices.
The vaccines and immunizations segment dominated the market revenue with 30.14% share in 2025 due to rising global vaccination programs, increased awareness of infectious disease prevention, and government-led immunization initiatives.
The online pharmacies segment is projected to witness the fastest growth at a CAGR of 12.50% during the forecast period due to increasing digital healthcare adoption and convenience in home delivery of medical supplies.
Key trends include prefilled syringes, safety syringes, needle-stick prevention technologies, biologic drug delivery, home-based injections, connected injection devices, and growing use of high-quality glass and polymer syringe systems.
Download Sample Report of Syringes Market
Please fill out the form to request a customized copy of the research report.
